Natco Pharma Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹735.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.53 per cent from ₹739.10 crore. This corresponds to a year-on-year *(YoY) decline of 44.68 per cent.
Operating Profit
Operating Profit stands at ₹186.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 46.16 per cent from ₹127.60 crore. This corresponds to a year-on-year *(YoY) decline of 67.34 per cent.
PBDT
PBDT stands at ₹317.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 37.71 per cent from ₹230.20 crore. This corresponds to a year-on-year *(YoY) decline of 49.64 per cent.
Profit Before Tax
Profit Before Tax stands at ₹269.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 50.11 per cent from ₹179.80 crore. This corresponds to a year-on-year *(YoY) decline of 52.81 per cent.
Net Profit
Net Profit stands at ₹206.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 23.23 per cent from ₹269.00 crore. This represents a 57.01 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Natco Pharma Ltd News
Natco Pharma Ltd Earnings
- YOY
- QOQ
Natco Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natco Pharma Ltd Research Reports
Natco Pharma Ltd Financial Reports
Natco Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natco Pharma | -0.34% | -1.73% | -8.58% | -8.74% | -11.99% | -2.06% |
| Alembic Pharma | -2.50% | -1.31% | -0.78% | 9.19% | 15.08% | -16.32% |
| Concord Biotech | -0.31% | -2.51% | 1.67% | 16.75% | 19.91% | -13.54% |
| Marksans Pharma | -0.15% | 0.76% | 23.63% | 38.74% | 94.21% | 93.93% |
| Jubilant Pharmo | -0.18% | 2.32% | -3.30% | -6.93% | 8.32% | -15.23% |
| Corona Remedies | 3.60% | 2.49% | -1.46% | 25.44% | 38.62% | 48.55% |
| Akums Drugs | 1.49% | 0.96% | 16.85% | 40.24% | 66.77% | 67.41% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : V C Nannapaneni
Vice Chairman & Chief Executive Officer : Rajeev Nannapaneni
ED / EVP : PSRK Prasad
ED / President : D Linga Rao
Independent Non Exe. Director : A D Murthy Chavali
Independent Non Exe. Director : Vijayabhaskar Dronadula
Independent Non Exe. Director : B. Lakshminarayana
Independent Non Exe. Director : Kantipudi Suma
Independent Non Exe. Director : Nitin Jain
Company Sec. & Compli. Officer : Chekuri Venkat Ramesh